|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6831 USD | +1.94% |
|
-14.24% | -51.55% |
| Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
| Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Lucid Diagnostics Inc. announced that it will receive $5,000,000 in funding on October 18, 2023. The company will issue common shares in the transaction. The minimum investment accepted from any outside investor is $250,000.
The company will issue securities pursuant to exemption provided under Regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| -51.55% | 32.96M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +6.20% | 5.84B | |
| +5.99% | 5.07B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.36% | 2.02B |
LUCID DIAGNOSTICS INC. 
